CA13 | Carbonic anhydrase XIII | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
CA2 | Carbonic anhydrase II | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CA4 | Carbonic anhydrase IV | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CA9 | Carbonic anhydrase IX | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CACNA1A | Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
CALML4 | Calmodulin-like 4 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CAPN9 | Calpain 9 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
CBLC | Cbl proto-oncogene C, E3 ubiquitin protein ligase | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
CCK | Cholecystokinin | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CCL15 | Chemokine (C-C motif) ligand 15 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CCL24 | Chemokine (C-C motif) ligand 24 | Predicted secreted proteins
| | | | | Tissue enhanced |
CD70 | CD70 molecule | Cancer-related genes CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CDC42EP5 | CDC42 effector protein (Rho GTPase binding) 5 | Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CDHR5 | Cadherin-related family member 5 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CEA | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000469926} | Predicted secreted proteins
| | | | | Tissue enhanced |
CEACAM1 | Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CEACAM5 | Carcinoembryonic antigen-related cell adhesion molecule 5 | Cancer-related genes CD markers Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CES3 | Carboxylesterase 3 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CKMT1B | Creatine kinase, mitochondrial 1B | Enzymes FDA approved drug targets Mitochondrial proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CLDN23 | Claudin 23 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CLDN3 | Claudin 3 | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC4F | C-type lectin domain family 4, member F | Predicted membrane proteins
| | | | | Tissue enhanced |
CLIC6 | Chloride intracellular channel 6 | Predicted intracellular proteins Transporters
| | | | | Tissue enhanced |
COL2A1 | Collagen, type II, alpha 1 | Cancer-related genes Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
CPA6 | Carboxypeptidase A6 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
CRYBA2 | Crystallin, beta A2 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
CTD-2510F5.6 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000464167} | Predicted intracellular proteins
| | | | | Tissue enhanced |
CTD-2545M3.6 | | Predicted intracellular proteins
| | | | | Tissue enhanced |
CXCL17 | Chemokine (C-X-C motif) ligand 17 | Predicted secreted proteins
| | | | | Tissue enhanced |
CYP2C18 | Cytochrome P450, family 2, subfamily C, polypeptide 18 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CYP2C19 | Cytochrome P450, family 2, subfamily C, polypeptide 19 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CYP2J2 | Cytochrome P450, family 2, subfamily J, polypeptide 2 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
CYP2S1 | Cytochrome P450, family 2, subfamily S, polypeptide 1 | Enzymes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CYP3A5 | Cytochrome P450, family 3, subfamily A, polypeptide 5 | Cancer-related genes Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CYP4F12 | Cytochrome P450, family 4, subfamily F, polypeptide 12 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
DAB1 | Dab, reelin signal transducer, homolog 1 (Drosophila) | Predicted intracellular proteins
| | | | | Tissue enhanced |
DCHS2 | Dachsous cadherin-related 2 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
DDC | Dopa decarboxylase (aromatic L-amino acid decarboxylase) | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
DEGS2 | Delta(4)-desaturase, sphingolipid 2 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
DHDH | Dihydrodiol dehydrogenase (dimeric) | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
DHRS9 | Dehydrogenase/reductase (SDR family) member 9 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DNASE1 | Deoxyribonuclease I | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DPEP1 | Dipeptidase 1 (renal) | Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
DPP4 | Dipeptidyl-peptidase 4 | CD markers Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DQX1 | DEAQ box RNA-dependent ATPase 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
DUSP4 | Dual specificity phosphatase 4 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
EDN2 | Endothelin 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
EDN3 | Endothelin 3 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
ENPEP | Glutamyl aminopeptidase (aminopeptidase A) | CD markers Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ENPP3 | Ectonucleotide pyrophosphatase/phosphodiesterase 3 | CD markers Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |